Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > HME article acquisitions/M&A -nothing like JUNK to buy...IMO
View:
Post by besttobe on Oct 18, 2022 5:48pm

HME article acquisitions/M&A -nothing like JUNK to buy...IMO

M&A WATCH: DEALS SLOW, BUT INTEREST REMAINS

Brad SmithYARMOUTH, Maine – With a certain amount of unpredictability settling over the HME industry, buyers are becoming more conservative, say M&A analysts. 

Case in point: the CPAP market. While providers say they may be seeing a light at the end of the tunnel as equipment becomes available and lead times shorten, it remains difficult to forecast, say analysts. 

“It’s hard (for sellers) to predict with great certainty what the future is going to look like,” said Pat Clifford, managing director, home medical equipment, for The Braff Group.  “(They used to be able to say), ‘We can set up X number of patients,’ but that’s much more difficult to do in the current environment. That plays into the M&A equation and buyers get more conservative in the purchase price.” 

Also affecting the equation: Core inflation and gas prices are up, lowering net income and putting a crimp in free cash flow, while interest rates are rising, say analysts. 

“This year, the cycle is running longer, due diligence is lasting longer and it’s doing that because of everything going on in the market right now,” said Brad Smith, managing director and partner at Vertess.“Interest rates are increasing, and cost of labor factors are weighing on the credit market, tightening it up.” 

Despite several headwinds, there is still significant interest in the market, say analysts. While smaller, less-established companies may not command high valuations, buyers are still eyeing larger companies, as well as those that are strategically positioned. 

“Whether it be with the contracts they hold, geography or specific product lines, we are still seeing a lot of activity and I think that is evidenced by the closings that occur over the next few months as everybody rushes for the year-end closings,” said Jonathan Sadock, managing partner with Paragon Ventures. 

Diabetes supply is still a very strong sector, as is the infusion sector, both home and alternate site, says Sadock.  

“The alternate site infusion sector is just really blooming,” he said. “It continues to have strong valuations and incredible growth. That’s an interesting dynamic right now in the market.”

Comment by LongTerm3 on Oct 19, 2022 3:23pm
The prices may be coming down. If earnings are good they can do a combination of cash and stock as long as it is accretive to earnings.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities